Ern Xin Joan Tan

Ms. Ern Xin Joan Tan

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
ETErn Xin Joan Tan
Ern Xin Joan Tan
MKMattias Wei Ren Kon
Mattias Wei Ren Kon
CTCharmaine Su Min Tan
Charmaine Su Min Tan
KZKevin Xiang Zhou
Kevin Xiang Zhou
KSKewin Tien Ho Siah
Kewin Tien Ho Siah
Qin Xiang NgQin Xiang Ng
Qin Xiang Ng
Background/Objectives: Breast cancer is the most common malignancy among women globally, with survival rates improving due to earlier detection and better treatment. As a result, cancer survivors now constitute a growing segment of the population, and addressing their long-term health and well-being is a public health priority. Diet and nutrition represent modifiable factors that may influence recurrence, comorbidities, and quality of life (QoL), yet clear evidence-based guidance remains limited. This umbrella review thus synthesized evidence from published reviews on the effects of dietary and nutrition interventions among breast cancer survivors. Methods: Following a prospectively registered protocol in PROSPERO (CRD420251185022), six databases (PubMed, EMBASE, Scopus, Cochrane Library, PsycINFO and CINAHL) were systematically searched for systematic reviews/meta-analyses evaluating dietary or nutrition interventions in adult breast cancer survivors. Eligible reviews reported anthropometric, metabolic, psychosocial, or survival outcomes. Methodological quality was appraised using the AMSTAR-2 tool, and findings were narratively synthesized. Results: Nine systematic reviews encompassing more than 10,000 breast cancer survivors were included. Interventions ranged from general dietary counselling and structured weight-management programmes to Mediterranean-style dietary patterns, dietitian-led primary care, multiple health behaviour change interventions, mobile nutrition apps, and broader lifestyle programmes incorporating diet. Across reviews, interventions consistently improved diet quality and fruit–vegetable intake, produced modest but meaningful reductions in weight, body mass index, and body fat, and enhanced several QoL domains (e.g., fatigue, physical functioning, body image). Higher adherence to Mediterranean-style diets was associated with lower all-cause and non–breast cancer mortality, though certainty was limited by observational designs. However, evidence for long-term maintenance, survival endpoints, and ethnically diverse or low- and middle-income populations remains sparse. Conclusions: Dietary and nutrition interventions, particularly structured, dietitian-supported, and Mediterranean-style approaches, contribute to improved diet quality, sustainable weight control, and enhanced QoL among breast cancer survivors. Integrating nutrition care into survivorship pathways should be the focus of future research.

25 September 2026 in Journal of Medical Internet Research
Verified
Journal Article
Open access
BYBrian Sheng Yep Yeo
Brian Sheng Yep Yeo
EGEsther Yanxin Gao
Esther Yanxin Gao
ETErn Xin Joan Tan
Ern Xin Joan Tan
JKJun Yuan Koo
Jun Yuan Koo
YLYi Siang Lee
Yi Siang Lee
STSong Tar Toh
Song Tar Toh
Background: The traditional method for diagnosing obstructive sleep apnea (OSA) through polysomnography may be expensive and inaccessible. Recent developments in AI propose the use of photoplethysmography (PPG) to aid OSA diagnosis. Objective: This study seeks to evaluate the diagnostic accuracy of an AI-based approach in diagnosing OSA using PPG. Methods: PubMed, Embase, Scopus, Web of Science, and IEEE Xplore were searched from inception to November 3, 2025. The inclusion criteria comprised observational studies that evaluated the accuracy of AI-based methods of OSA diagnosis using PPG compared with conventional sleep testing used in adults. We excluded case reports, case series, reviews, meta-analyses, letters, conference abstracts, pediatric studies, animal studies, foreign language studies, studies with incomplete data, and studies focusing on individual apneic events without patient-level classification. The outcome of interest was the diagnostic accuracy of PPG-based AI models for OSA, as assessed in primary studies using random split tests, cross-validation, or external validation. Independent reviewers extracted data and assessed risk of bias using the QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies-2) tool. A Bayesian bivariate meta-analysis was used to pool estimates. Further subgroup, sensitivity, and meta-regression analyses were conducted. Overall quality of evidence was assessed using the GRADE (Grading of Recommendations, Assessment, Development and Evaluations) framework. Results: From 12,579 records, we included 13 studies, comprising 9983 participants. All studies were rated as either low or unclear for risk of bias. The overall evidence quality was moderate. AI trained on PPG achieved a pooled sensitivity of 79.6% (95% credible interval [CrI] 55.5%‐93.8%) and specificity of 76.5% (95% CrI 48.2%‐94.0%), compared to conventional diagnosis. The overall specificity increased (apnea-hypopnea index [AHI] ≥5: 63.6%; AHI ≥15: 81.8%; AHI ≥30: 85.1%), but overall sensitivity decreased (AHI ≥5: 87.2%; AHI ≥15: 79.7%; AHI ≥30: 76.7%) with greater categorical AHI severity cutoffs. Additionally, deep learning models achieved a higher specificity (82.9%) than traditional machine learning (63.6%). OSA prevalence and device type were not clearly associated with sensitivity or specificity. Conclusions: AI models trained on PPG have reasonable accuracy and may potentially serve as a low-cost screening tool. However, limitations such as small sample sizes, potential sources of bias, underrepresentation of certain geographic regions, and the influence of potential confounding factors highlight the necessity for further research. Future work should focus on deep learning to improve the feasibility and accessibility of this approach in primary care.